Literature DB >> 21849980

Baseline brain metabolism in resistant depression and response to transcranial magnetic stimulation.

Marie-Laure Paillère Martinot1, Jean-Luc Martinot, Damien Ringuenet, André Galinowski, Thierry Gallarda, Frank Bellivier, Jean-Pascal Lefaucheur, Hervé Lemaitre, Eric Artiges.   

Abstract

Neuroimaging studies of patients with treatment-resistant depression (TRD) have reported abnormalities in the frontal and temporal regions. We sought to determine whether metabolism in these regions might be related to response to repetitive transcranial magnetic stimulation (TMS) in patients with TRD. Magnetic resonance images and baseline resting-state cerebral glucose uptake index (gluMI) obtained using (18)F-fluorodeoxyglucose positron emission tomography were analyzed in TRD patients who had participated in a double-blind, randomized, sham-controlled trial of prefrontal 10 Hz TMS. Among the patients randomized to active TMS, 17 responders, defined as having 50% depression score decrease, and 14 nonresponders were investigated for prestimulation glucose metabolism and compared with 39 healthy subjects using a voxel-based analysis. In nonresponders relative to responders, gluMI was lower in left lateral orbitofrontal cortex (OFC), and higher in left amygdala and uncinate fasciculus. OFC and amygdala gluMI negatively correlated in nonresponders, positively correlated in responders, and did not correlate in healthy subjects. Relative to healthy subjects, both responders and nonresponders displayed lower gluMI in right dorsolateral prefrontal (DLPFC), right anterior cingulate (ACC), and left ventrolateral prefrontal cortices. Additionally, nonresponders had lower gluMI in left DLPFC, ACC, left and right insula, and higher gluMI in left amygdala and uncus. Hypometabolisms were partly explained by gray matter reductions, whereas hypermetabolisms were unrelated to structural changes. The findings suggest that different patterns of frontal-temporal-limbic abnormalities may distinguish responders and nonresponders to prefrontal magnetic stimulation. Both preserved OFC volume and amygdala metabolism might precondition response to TMS.

Entities:  

Mesh:

Year:  2011        PMID: 21849980      PMCID: PMC3230494          DOI: 10.1038/npp.2011.161

Source DB:  PubMed          Journal:  Neuropsychopharmacology        ISSN: 0893-133X            Impact factor:   7.853


  48 in total

1.  Functional anatomical correlates of antidepressant drug treatment assessed using PET measures of regional glucose metabolism.

Authors:  Wayne C Drevets; Wendy Bogers; Marcus E Raichle
Journal:  Eur Neuropsychopharmacol       Date:  2002-12       Impact factor: 4.600

2.  Effects of mood and subtype on cerebral glucose metabolism in treatment-resistant bipolar disorder.

Authors:  T A Ketter; T A Kimbrell; M S George; R T Dunn; A M Speer; B E Benson; M W Willis; A Danielson; M A Frye; P Herscovitch; R M Post
Journal:  Biol Psychiatry       Date:  2001-01-15       Impact factor: 13.382

3.  Changes in prefrontal cortex and paralimbic activity in depression following two weeks of daily left prefrontal TMS.

Authors:  C C Teneback; Z Nahas; A M Speer; M Molloy; L E Stallings; K M Spicer; S C Risch; M S George
Journal:  J Neuropsychiatry Clin Neurosci       Date:  1999       Impact factor: 2.198

Review 4.  The burden of disease for treatment-resistant depression.

Authors:  J F Greden
Journal:  J Clin Psychiatry       Date:  2001       Impact factor: 4.384

5.  Neuroimaging studies of mood disorders.

Authors:  W C Drevets
Journal:  Biol Psychiatry       Date:  2000-10-15       Impact factor: 13.382

6.  Differential cerebral metabolic changes with paroxetine treatment of obsessive-compulsive disorder vs major depression.

Authors:  Sanjaya Saxena; Arthur L Brody; Matthew L Ho; Shervin Alborzian; Karron M Maidment; Narineh Zohrabi; Mai K Ho; Sung-Cheng Huang; Hsiao-Ming Wu; Lewis R Baxter
Journal:  Arch Gen Psychiatry       Date:  2002-03

7.  Correlation of cerebral blood flow and treatment effects of repetitive transcranial magnetic stimulation in depressed patients.

Authors:  Felix M Mottaghy; Christian E Keller; Massimo Gangitano; Jennifer Ly; Mark Thall; J Anthony Parker; Alvaro Pascual-Leone
Journal:  Psychiatry Res       Date:  2002-08-20       Impact factor: 3.222

Review 8.  The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10.

Authors:  D V Sheehan; Y Lecrubier; K H Sheehan; P Amorim; J Janavs; E Weiller; T Hergueta; R Baker; G C Dunbar
Journal:  J Clin Psychiatry       Date:  1998       Impact factor: 4.384

9.  Cerebral blood flow changes in depressed patients after treatment with repetitive transcranial magnetic stimulation: evidence of individual variability.

Authors:  Stephen E Nadeau; Karin J M McCoy; Gregory P Crucian; Richard A Greer; Fabian Rossi; Dawn Bowers; Wayne K Goodman; Kenneth M Heilman; William J Triggs
Journal:  Neuropsychiatry Neuropsychol Behav Neurol       Date:  2002-09

Review 10.  The human amygdala and the emotional evaluation of sensory stimuli.

Authors:  David H Zald
Journal:  Brain Res Brain Res Rev       Date:  2003-01
View more
  19 in total

1.  Prospective Validation That Subgenual Connectivity Predicts Antidepressant Efficacy of Transcranial Magnetic Stimulation Sites.

Authors:  Anne Weigand; Andreas Horn; Ruth Caballero; Danielle Cooke; Adam P Stern; Stephan F Taylor; Daniel Press; Alvaro Pascual-Leone; Michael D Fox
Journal:  Biol Psychiatry       Date:  2017-11-10       Impact factor: 13.382

2.  Acute and repetitive fronto-cerebellar tDCS stimulation improves mood in non-depressed participants.

Authors:  Simon Newstead; Hayley Young; David Benton; Gabriela Jiga-Boy; Maria L Andrade Sienz; R M Clement; Frédéric Boy
Journal:  Exp Brain Res       Date:  2017-11-02       Impact factor: 1.972

3.  Pretreatment cerebral metabolic activity correlates with antidepressant efficacy of vagus nerve stimulation in treatment-resistant major depression: a potential marker for response?

Authors:  Charles R Conway; John T Chibnall; Sunil Gangwani; Mark A Mintun; Joseph L Price; Tamara Hershey; Luis A Giuffra; Richard D Bucholz; Jon J Christensen; Yvette I Sheline
Journal:  J Affect Disord       Date:  2012-03-05       Impact factor: 4.839

4.  Identification of Clinical Features and Biomarkers that may inform a Personalized Approach to rTMS for Depression.

Authors:  Sarah L Garnaat; Andrew M Fukuda; Shiwen Yuan; Linda L Carpenter
Journal:  Pers Med Psychiatry       Date:  2019-10-18

Review 5.  Biological markers in noninvasive brain stimulation trials in major depressive disorder: a systematic review.

Authors:  Thiago M Fidalgo; J Leon Morales-Quezada; Guilherme S C Muzy; Noelle M Chiavetta; Mariana E Mendonca; Marcus V B Santana; Oscar F Goncalves; Andre R Brunoni; Felipe Fregni
Journal:  J ECT       Date:  2014-03       Impact factor: 3.635

6.  Repetitive Transcranial Magnetic Stimulation Improves Neurological Function and Promotes the Anti-inflammatory Polarization of Microglia in Ischemic Rats.

Authors:  Jing Luo; Yuan Feng; Mingyue Li; Mingyu Yin; Feng Qin; Xiquan Hu
Journal:  Front Cell Neurosci       Date:  2022-04-12       Impact factor: 5.505

7.  Interoception Dysfunction Contributes to the Negative Emotional Bias in Major Depressive Disorder.

Authors:  Hongliang Zhou; Haowen Zou; Zhongpeng Dai; Shuai Zhao; Lingling Hua; Yi Xia; Yingling Han; Rui Yan; Hao Tang; Yinghong Huang; Yishan Du; Xiaoqin Wang; Zhijian Yao; Qing Lu
Journal:  Front Psychiatry       Date:  2022-04-11       Impact factor: 5.435

Review 8.  Neuroimaging-based biomarkers for treatment selection in major depressive disorder.

Authors:  Boadie W Dunlop; Helen S Mayberg
Journal:  Dialogues Clin Neurosci       Date:  2014-12       Impact factor: 5.986

9.  Major depressive disorder and alterations in insular cortical activity: a review of current functional magnetic imaging research.

Authors:  Diane Sliz; Shawn Hayley
Journal:  Front Hum Neurosci       Date:  2012-12-03       Impact factor: 3.169

10.  Magnetic seizure therapy for treatment-resistant depression.

Authors:  Jiangling Jiang; Caidi Zhang; Chunbo Li; Zhimin Chen; Xinyi Cao; Hongyan Wang; Wei Li; Jijun Wang
Journal:  Cochrane Database Syst Rev       Date:  2021-06-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.